Elevated levels of immunoglobulin G (IgG) drive “inflammaging” processes that take a toll on skin tissue as people age, according to research results reported by Japanese researchers. Reducing IgG may mitigate the loss of collagen and elastin.
|Slideshows|June 12, 2021
- MHE June 2021
- Volume 31
- Issue 6
2021 Managed Healthcare Executive® Pharmacy Survey: Most Effective Ways to Reduce Pharmaceutical Costs
Author(s)MHE Staff
In this part three series, participants give their opinions on the most effective ways to reduce traditional and specialty pharmaceutical costs. MHE's annual pharmacy survey had over 225 respondents. We will be posting the results over the next several days.
Advertisement
Results from our 2021 Pharmacy survey show that there is no big winner when it comes to opinions on the most effective way to rein in drug costs. Answers to the question about the most effective way to reduce costs for traditional and specialty pharmacy costs were pretty evenly distributed when we asked respondents to pick up to three of eight choices.
For traditional pharmacy, expanded use of digital tools (30%), improved price transparency (30%), narrower, simpler formularies (29%), revised benefit design to steer patients to low-cost options (29%) and more aggressive utilization management (28%) were favored by roughly the same proportion of respondents.
For specialty pharmacy, there was a bit more separation of the top picks from the rest of the pack. Most favored was performance-based contracting between payers and prescribers (42%), followed by Medicare price negotiation (36%) and formulary adoption and prescription of biosimilars (35%).
Just over 225 people responded to our online survey between April 5 and May 10.
Articles in this issue
over 5 years ago
Amazon vs. Traditional Healthcare: Who Will Win?over 5 years ago
Birth Control is Also Part of Sexual Healthover 5 years ago
Rising STD Trend, Interruptedover 5 years ago
At-home Dialysis on The Riseover 5 years ago
Results from 2021 Managed Healthcare Executive® Pharmacy Surveyover 5 years ago
Psychedelics Take a Long, Strange Trip to RespectabilityAdvertisement
Related to this article
Pharmacy benefit managers are moving beyond formulary access to provide support programs for women's health. Here's how three PBMs — Judi Health, LucyRx and RxPreferred — are putting that strategy into practice.
Women face more gaps in healthcare than men, from missed screenings, undertreatment and biased coverage. PBMs are launching programs to address some of the gaps.
ProAct Chief Operating Offier Deborah Dempsey says plan sponsors still lack the data and visibility to know whether they were shorted on a 340B claim.
AACR Cancer Progress Report 2026 highlights a 35% U.S. cancer death decline, new FDA advances, persistent disparities, and urgent calls for stronger NIH/NCI funding.
OrionRx's Don Anderson, Pharm.D., says a GLP-1 access model built around mandatory wellness coaching resulted in a six-point drop in body mass index and improved mental health.
Yellow eyelid Xanthelasma signals hidden high cholesterol and cardiovascular disease risk, tripling heart attack and stroke odds; Negin Yavari, M.D., and her team urge screening.
Maladaptive coping at baseline raised relapse and symptom risk over 12 months in first episode psychosis, King's College London researchers found.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Navitus launches GLP-1 drug management programs
2
New AACR report has found U.S. Cancer death rate dropped 35% since 1991
3
Growth of GLP-1 therapies has reshaped the market | PBMI 2026
4
Judi Health, Employers Health team up to launch new PBM solution
5